PTPRC and neoplasm: The CD45+ and CD31+ cell populations were significantly increased in tumor tissues from MiaPaCA-2/CTHRC1 cell-injected mice compared with those from mice injected with MiaPaCa-2/Mock cells (Figure 1a), indicating that CTHRC1 has the potential to modulate vascularity.